142. Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
作者: .;Jeffrey G Gross.;Adam R Glassman.;Lee M Jampol.;Seidu Inusah.;Lloyd Paul Aiello.;Andrew N Antoszyk.;Carl W Baker.;Brian B Berger.;Neil M Bressler.;David Browning.;Michael J Elman.;Frederick L Ferris.;Scott M Friedman.;Dennis M Marcus.;Michele Melia.;Cynthia R Stockdale.;Jennifer K Sun.;Roy W Beck.
来源: JAMA. 2015年314卷20期2137-2146页
Panretinal photocoagulation (PRP) is the standard treatment for reducing severe visual loss from proliferative diabetic retinopathy. However, PRP can damage the retina, resulting in peripheral vision loss or worsening diabetic macular edema (DME).
144. Effect of Intravascular Ultrasound-Guided vs Angiography-Guided Everolimus-Eluting Stent Implantation: The IVUS-XPL Randomized Clinical Trial.
作者: Sung-Jin Hong.;Byeong-Keuk Kim.;Dong-Ho Shin.;Chung-Mo Nam.;Jung-Sun Kim.;Young-Guk Ko.;Donghoon Choi.;Tae-Soo Kang.;Woong-Chol Kang.;Ae-Young Her.;Yong Hoon Kim.;Seung-Ho Hur.;Bum-Kee Hong.;Hyuckmoon Kwon.;Yangsoo Jang.;Myeong-Ki Hong.; .
来源: JAMA. 2015年314卷20期2155-63页
Use of intravascular ultrasound (IVUS) promotes better clinical outcomes for coronary intervention in complex coronary lesions. However, randomized data demonstrating the clinical usefulness of IVUS are limited for lesions treated with drug-eluting stents.
145. Effect of Clopidogrel and Aspirin vs Aspirin Alone on Migraine Headaches After Transcatheter Atrial Septal Defect Closure: The CANOA Randomized Clinical Trial.
作者: Josep Rodés-Cabau.;Eric Horlick.;Reda Ibrahim.;Asim N Cheema.;Marino Labinaz.;Najaf Nadeem.;Mark Osten.;Mélanie Côté.;Josep Ramon Marsal.;Donald Rivest.;Alier Marrero.;Christine Houde.
来源: JAMA. 2015年314卷20期2147-54页
The occurrence of new-onset migraine attacks is a complication of transcatheter atrial septal defect (ASD) closure. It has been suggested that clopidogrel may reduce migraine attacks after ASD closure.
146. Appropriate Use Criteria for Coronary Revascularization and Trends in Utilization, Patient Selection, and Appropriateness of Percutaneous Coronary Intervention.
作者: Nihar R Desai.;Steven M Bradley.;Craig S Parzynski.;Brahmajee K Nallamothu.;Paul S Chan.;John A Spertus.;Manesh R Patel.;Jeremy Ader.;Aaron Soufer.;Harlan M Krumholz.;Jeptha P Curtis.
来源: JAMA. 2015年314卷19期2045-53页
Appropriate Use Criteria for Coronary Revascularization were developed to critically evaluate and improve patient selection for percutaneous coronary intervention (PCI). National trends in the appropriateness of PCI have not been examined.
155. Consistency of Laboratory Monitoring During Initiation of Mineralocorticoid Receptor Antagonist Therapy in Patients With Heart Failure.
作者: Lauren B Cooper.;Bradley G Hammill.;Eric D Peterson.;Bertram Pitt.;Matthew L Maciejewski.;Lesley H Curtis.;Adrian F Hernandez.
来源: JAMA. 2015年314卷18期1973-5页 158. Does This Patient With Chest Pain Have Acute Coronary Syndrome?: The Rational Clinical Examination Systematic Review.
作者: Alexander C Fanaroff.;Jennifer A Rymer.;Sarah A Goldstein.;David L Simel.;L Kristin Newby.
来源: JAMA. 2015年314卷18期1955-65页
About 10% of patients with acute chest pain are ultimately diagnosed with acute coronary syndrome (ACS). Early, accurate estimation of the probability of ACS in these patients using the clinical examination could prevent many hospital admissions among low-risk patients and ensure that high-risk patients are promptly treated.
159. Prevalence and Correlates of Myocardial Scar in a US Cohort.
作者: Evrim B Turkbey.;Marcelo S Nacif.;Mengye Guo.;Robyn L McClelland.;Patricia B R P Teixeira.;Diane E Bild.;R Graham Barr.;Steven Shea.;Wendy Post.;Gregory Burke.;Matthew J Budoff.;Aaron R Folsom.;Chia-Ying Liu.;João A Lima.;David A Bluemke.
来源: JAMA. 2015年314卷18期1945-54页
Myocardial scarring leads to cardiac dysfunction and poor prognosis. The prevalence of and factors associated with unrecognized myocardial infarction and scar have not been previously defined using contemporary methods in a multiethnic US population.
160. Endovascular Revascularization and Supervised Exercise for Peripheral Artery Disease and Intermittent Claudication: A Randomized Clinical Trial.
作者: Farzin Fakhry.;Sandra Spronk.;Lijckle van der Laan.;Jan J Wever.;Joep A W Teijink.;Wolter H Hoffmann.;Taco M Smits.;Jerome P van Brussel.;Guido N M Stultiens.;Alex Derom.;P Ted den Hoed.;Gwan H Ho.;Lukas C van Dijk.;Nicole Verhofstad.;Mariella Orsini.;Andre van Petersen.;Kristel Woltman.;Ingrid Hulst.;Marc R H M van Sambeek.;Dimitris Rizopoulos.;Ellen V Rouwet.;M G Myriam Hunink.
来源: JAMA. 2015年314卷18期1936-44页
Supervised exercise is recommended as a first-line treatment for intermittent claudication. Combination therapy of endovascular revascularization plus supervised exercise may be more promising but few data comparing the 2 therapies are available.
|